Table of Contents
Journal of Blood Transfusion
Volume 2014, Article ID 204301, 4 pages
http://dx.doi.org/10.1155/2014/204301
Research Article

Testing for Partial RhD with a D-Screen Diagast Kit in Moroccan Blood Donors with Weak D Expression

1Centre National de Transfusion Sanguine, rue Lamfadel Cherkaoui, Madinat Al Irfane, P.O. Box 180, 10000 Rabat, Morocco
2Departement de Biologie, Faculté des Sciences, University MDV Rabat Agdal, 1014 Rabat, Morocco
3Centre Regional de Transfusion Sanguine, rue Lamfadel Cherkaoui, Madinat Al Irfane, P.O. Box 180, 10000 Rabat, Morocco

Received 5 July 2014; Revised 19 September 2014; Accepted 26 September 2014; Published 28 October 2014

Academic Editor: Maria Rios

Copyright © 2014 Z. Kabiri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Chiaroni, V. Ferrera, I. Dettori, and F. Roubinet, “Groupes sanguins érythrocytaires: red-cell blood groups,” EMC: Hématologie, vol. 2, no. 2, pp. 53–112, 2005. View at Publisher · View at Google Scholar
  2. W. A. Flegel and F. F. Wagner, “Molecular biology of partial D and weak D: implications for blood bank practice,” Clinical Laboratory, vol. 48, no. 1-2, pp. 53–59, 2002. View at Google Scholar · View at Scopus
  3. J. Chiaroni, M. Touinssi, S. Chapel-Fernandes, T. Granier, A. Bokilo, and P. Bailly, “Molecular analysis of inactive and active RHD alleles in native Congolese cohorts,” Transfusion, vol. 49, no. 7, pp. 1353–1360, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. Z. Kabiri, M. Benajiba, K. Hajjout, N. Dakka, and H. Bellaoui, “Weak D prevalence among Rh D negative blood donors in Morocco,” Immuno-Analyse et Biologie Specialisee, vol. 28, no. 1, pp. 36–38, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. K. F. K. Fung, E. Eason, J. Crane et al., “Maternal fetal medicinal committee, genetics committee prevention of Rh alloimmunisation,” Journal of Obstetrics & Gynaecology, vol. 25, pp. 765–773, 2003. View at Google Scholar
  6. S. S. Kulkarni, K. Vasantha, S. C. Gupte, D. Mohanty, and K. Ghosh, “Potential of commercial anti-D reagents in the identification of partial D variants in Indian population,” Indian Journal of Medical Research, vol. 125, no. 5, pp. 641–644, 2007. View at Google Scholar · View at Scopus
  7. J. Jones, M. L. Scott, and D. Voak, “Monoclonal anti-D specificity and Rh D structure: criteria for selection of monoclonal anti-D reagents for routine typing of patients and donors,” Transfusion Medicine, vol. 5, no. 3, pp. 171–184, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. J. W. Jones, D. Voak, M. L. Scott, and H. H. Sonneborn, “Policies for the selection of monoclonal RHD typing reagents,” Biotest Bulletin, vol. 5, pp. 485–494, 1997. View at Google Scholar
  9. F. F. Wagner, D. Kasulke, M. Kerowgan, and W. A. Flegel, “Frequencies of the blood groups ABO, Rhesus, D category VI, Kell, and of clinical relevant high-frequency antigens in South-Western Germany,” Infusionstherapie und Transfusionsmedizin, vol. 22, no. 5, pp. 285–290, 1995. View at Google Scholar · View at Scopus
  10. P. Tippett, C. Lomas-Francis, and M. Wallace, “The Rh antigen D: partial D antigens and associated low incidence antigens,” Vox Sanguinis, vol. 70, no. 3, pp. 123–131, 1996. View at Google Scholar · View at Scopus
  11. N. D. Avent, J. Poole, B. K. Singleton et al., “Studies of two partial Ds: DMH and DOL,” Transfusion Medicine, vol. 9, supplement 1, p. 33, 1999. View at Google Scholar
  12. C. Loma, P. Tippett, K. M. Thompson, M. D. Melamed, and N. C. Hughes-Jones, “Demonstration of seven epitopes on the Rh antigen D using human monoclonal anti-D antibodies and red cells from D categories,” Vox Sanguinis, vol. 57, no. 4, pp. 261–264, 1989. View at Publisher · View at Google Scholar · View at Scopus
  13. N. D. Avent, W. Liu, J. W. Jones et al., “Molecular analysis of Rh transcripts and polypeptides from individuals of Rh transcripts and polypeptides from individuals expressing the DVI variant phenotype and RHD gene deletion event does not generate all DVI phenotype and RHD gene deletion event does not generate all DVI ccEe phenotypes,” Blood, vol. 83, pp. 1129–1135, 1994. View at Google Scholar
  14. C. P. Engelfriet, H. W. Reesink, G. F. Körmöczi et al., “Testing for weak D,” Vox Sanguinis, vol. 90, no. 2, pp. 140–153, 2006. View at Publisher · View at Google Scholar
  15. B.-N. Pham, M. Roussel, T. Peyrard et al., “Anti-D investigations in individuals expressing weak D Type 1 or weak D Type 2: allo- or autoantibodies?” Transfusion, vol. 51, no. 12, pp. 2679–2685, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. F. F. Wagner, C. Gassner, T. H. Müller, D. Schönitzer, F. Schunter, and W. A. Flegel, “Three molecular structures cause rhesus D category VI phenotypes with distinct immunohematologic features,” Blood, vol. 91, no. 6, pp. 2157–2168, 1998. View at Google Scholar · View at Scopus
  17. Wissenschaftlicher Beirat der Bundesärztekammer Paul-Ehrlich-Institut, Richtlinien zur Blutgruppenbestimmung und Bluttransfusion (Hämotherapie), Deutscher Ärzte, Köln, Germany, 1996.
  18. H. G. Klein, Standards for Blood Banks and Transfusion Services, American Association of Blood Banks, 1996.